Ranbaxy

Drugs giant Ranbaxy faces a tough road ahead after US authorities imposed stiff conditions to settle a long legal battle over manufacturing safety violations at its plants, analysts say.
Ranbaxy

Share prices of Ranbaxy tumbled nearly 7 per cent in the morning trade after a consent decree was filed in a United States court that requires the drug firm to

Indian pharma major Ranbaxy faces the possibility of a permanent injunction which requires it to make fundamental changes to its plants both in the US and India and would prevent

Wiretap was the most successful weapon used by the US government to build the case against hedge fund manager Raj Rajaratnam in the infamous insider trading case involving millions of

Drug-maker Ranbaxy Laboratories today said it has signed an agreement with the US health regulator to lift a ban on the import of drugs from certain manufacturing plants in India and will pay up to $ 500 million to settle a case lodged by the Department of Justice.

Refuting claims of possible failure to launch generic Caduet Ranbaxy Laboratories on Friday said the launch would happen soon.